Anti-albumin x Anti-IL-6R Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-albumin and anti-IL-6R parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can act as PK-modulated receptor antagonist. It is designed for the research of Lupus, rheumatoid arthritis therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY